Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study - Concepedia

Concepedia

Publication | Open Access

Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

DOI Full Paper Access

10

Citations

21

References

2021

Year

Enzo Maria Ruggeri, Fabrizio Nelli, Agnese Fabbri, Angelo Onorato, Diana Giannarelli, Julio Rodrigo Giròn Berrìos, Antonella Virtuoso, Eleonora Marrucci, Marco Mazzotta, Marta Schirripa,

Abstract

Drugs interfering with DNA synthesis, multiple-agent cytotoxic chemotherapy, TKIs, mTOR and cyclin-dependent kinase 4/6 inhibitors differentially modulate humoral response to messenger RNA-BNT162b2 vaccine.

References

	Year	Citations

Page 1